Analysts See $1.35 EPS for China Biologic Products Holdings, Inc. (CBPO)

October 14, 2018 - By Darrin Black

Analysts expect China Biologic Products Holdings, Inc. (NASDAQ:CBPO) to report $1.35 EPS on November, 7.They anticipate $0.24 EPS change or 21.62 % from last quarter’s $1.11 EPS. CBPO’s profit would be $53.08M giving it 13.81 P/E if the $1.35 EPS is correct. After having $1.17 EPS previously, China Biologic Products Holdings, Inc.’s analysts see 15.38 % EPS growth. The stock increased 1.65% or $1.21 during the last trading session, reaching $74.59. About 151,352 shares traded. China Biologic Products Holdings, Inc. (NASDAQ:CBPO) has declined 14.60% since October 14, 2017 and is downtrending. It has underperformed by 30.22% the S&P500.

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. The company has market cap of $2.93 billion. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. It has a 36.14 P/E ratio. The firm also provides human immunoglobulin and immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus.

Another recent and important China Biologic Products Holdings, Inc. (NASDAQ:CBPO) news was published by Globenewswire.com which published an article titled: “Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and …” on September 26, 2018.

China Biologic Products Holdings, Inc. (NASDAQ:CBPO) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>